Gengiah, T. N., Heck, C. J., Lewis, L., Mansoor, L. E., Harkoo, I., Myeni, N., Baum, M. M., Moss, J. A., Rooney, J. F., Hankins, C., Pozzetto, B., Abdool Karim, S. S., & Abdool Karim, Q. (2025). Acceptability of an annual tenofovir alafenamide implant for HIV prevention in South African women: findings from the CAPRISA 018 Phase I clinical trial. Journal of the International AIDS Society, 28(2). Portico. https://doi.org/10.1002/jia2.26426

Heck, C. J., Kripke, K., Dam, A., Torres-Rueda, S., Bozzani, F., Obermeyer, C., Yohannes, K., Deacon, J., Meyers, K., Quigee, D., Wiant, S., Forsythe, S., Malati, C., Larson, M., Sobieszczyk, M. E., & Castor, D. (2024). Leveraging international stakeholders’ experiences with oral PrEP costs to accelerate implementation of the monthly dapivirine vaginal ring: A qualitative study. Health Research Policy and Systems, 22(1). https://doi.org/10.1186/s12961-024-01240-5

Christopoulos, K. A., Smith, M. B., Pareek, P., Dawdani, A., Erguera, X. A., Dance, K. V., Walker, R. S., Grochowski, J., Mayorga‐Munoz, F., Hickey, M. D., Johnson, M. O., Sauceda, J., Gutierrez, J. I., Montgomery, E. T., Colasanti, J. A., Collins, L. F., McNulty, M. C., & Koester, K. A. (2024). Learning from the first: a qualitative study of the psychosocial benefits and treatment burdens of long‐acting cabotegravir/rilpivirine among early adopters in three U.S. clinics. Journal of the International AIDS Society, 27(11). Portico. https://doi.org/10.1002/jia2.26394

Rael, C. T., Das, D., Porter, J., Lopez-Ríos, J., Abascal, E., Dolezal, C., Vaughn, M. P., Giffenig, P., Lopez, J. M., Stonbraker, S., Sun, C., Velasco, R. A., Bitterfeld, L., Bockting, W. O., & Bauermeister, J. (2024). Provider Factors Likely to Impact Access and Uptake of Long-Acting Injectable Cabotegravir for Transgender Women in the United States: Results of a Qualitative Study. Journal of the Association of Nurses in AIDS Care, 35(5), 437–449. https://doi.org/10.1097/jnc.0000000000000488

Bekker, A., Capparelli, E. V., Mirochnick, M., Clarke, D. F., Cotton, M. F., Shapiro, R., McCarthy, K., Moye, J., Violari, A., Chokephaibulkit, K., Abrams, E., Penazzato, M., Ruel, T. D., & Cressey, T. R. (2024). Lamivudine dosing for preterm infants exposed to HIV: a population pharmacokinetic modelling and simulation study. Journal of Antimicrobial Chemotherapy, 79(10), 2570–2574. https://doi.org/10.1093/jac/dkae259

Lelutiu-Weinberger, C., Filimon, M. L., Zavodszky, A. M., Lixandru, M., Hanu, L., Fierbinteanu, C., Patrascu, R., Streinu-Cercel, A., Luculescu, S., Bora, M., Filipescu, I., Jianu, C., Heightow-Weidman, L. B., Rochelle, A., Yi, B., Buckner, N., Golub, S. A., van Dyk, I. S., Burger, J., … Pachankis, J. E. (2024). Prepare Romania: study protocol for a randomized controlled trial of an intervention to promote pre-exposure prophylaxis adherence and persistence among gay, bisexual, and other men who have sex with men. Trials, 25(1). https://doi.org/10.1186/s13063-024-08313-4

Rousseau, E., Sikkema, K. J., Julies, R. F., Mazer, K., O’Malley, G., Heffron, R., Morton, J. F., Johnson, R., Celum, C., Baeten, J. M., & Bekker, L. (2024). Exploring adolescent girls and young women’s PrEP‐user profiles: qualitative insights into differentiated PrEP delivery platform selection and engagement in Cape Town, South Africa. Journal of the International AIDS Society, 27(5). Portico. https://doi.org/10.1002/jia2.26254

Peck, R. N., Issarow, B., Kisigo, G. A., Kabakama, S., Okello, E., Rutachunzibwa, T., Willkens, M., Deogratias, D., Hashim, R., Grosskurth, H., Fitzgerald, D. W., Ayieko, P., Lee, M. H., Murphy, S. M., Metsch, L. R., & Kapiga, S. (2024). Linkage Case Management and Posthospitalization Outcomes in People With HIV. JAMA, 331(12), 1025. https://doi.org/10.1001/jama.2024.2177

Maragh-Bass, A. C., Kiplagat, S., Lavari, S., Sastre, F., Devieux, J. G., Jimenez, D., Clarke, R. D., Noel, I., Schrimshaw, E. W., Sevelius, J., & Cyrus, E. (2024). Barriers to Accessing and Engaging in HIV Preventive Care and Pre-Exposure Prophylaxis Experienced by Transgender Women in Florida. International Journal of Environmental Research and Public Health, 21(3), 376. https://doi.org/10.3390/ijerph21030376

Knox, J., Aharonovich, E., Zingman, B. S., Stohl, M., Walsh, C., Elliott, J. C., Fink, D. S., Durant, S., Menchaca, R., Sharma, A., Denning, M., & Hasin, D. (2024). HealthCall: Smartphone Enhancement of Brief Interventions to Improve HIV Medication Adherence Among Patients in HIV Care. AIDS and Behavior, 28(6), 1912–1922. https://doi.org/10.1007/s10461-024-04289-z

Hatch, M. A., Laschober, T. C., Paschen-Wolff, M., Ertl, M. M., Nelson, C. M., Wright, L., Lancaster, C., Feaster, D. J., Forrest, D., Hankey, C., Monger, M., Fegley, J. P., Irving, R., Young, C., Rose, J., Spector, A., Dresser, L., Moran, L., Jelstrom, E., & Tross, S. (2024). PrEP for people who use opioids: A NIDA clinical trials network survey study in Southern U.S. cities where HIV incidence is high. Drug and Alcohol Dependence, 257, 111133. https://doi.org/10.1016/j.drugalcdep.2024.111133

McCrimmon, T., Collins, L. F., Perez-Brumer, A., Bazzi, A. R., Shaffer, V. A., Kerrigan, D., Alcaide, M. L., & Philbin, M. M. (2024). Long-Acting Injectable Antiretrovirals for HIV Treatment: A Multi-Site Qualitative Study of Clinic-Level Barriers to Implementation in the United States. AIDS Patient Care and STDs, 38(2), 61–69. https://doi.org/10.1089/apc.2023.0248

Singer, R. B., Barrow, J., Johnson, A. K., Zemlak, J., Crooks, N., Abboud, S., Bruce, D., Green, N., Stamps, J., Neely, J., Sherman, S. G., Patil, C. L., & Matthews, A. K. (2024). Centering PrEP: Utilizing ADAPT-ITT to inform group PrEP care for sex workers in Chicago. BMC Public Health, 24(1). https://doi.org/10.1186/s12889-023-17508-4

Trickey, A., Johnson, L. F., Fung, F., Bonifacio, R., Iwuji, C., Biraro, S., Bosomprah, S., Chirimuta, L., Euvrard, J., Fatti, G., Fox, M. P., Von Groote, P., Gumulira, J., Howard, G., Jennings, L., Kiragga, A., Muula, G., Tanser, F., Wagener, T., … Vickerman, P. (2023). Associations of inter-annual rainfall decreases with subsequent HIV outcomes for persons with HIV on antiretroviral therapy in Southern Africa: a collaborative analysis of cohort studies. BMC Infectious Diseases, 23(1). https://doi.org/10.1186/s12879-023-08902-9

Krogstad Mudzingwa, E., de Vos, L., Atujuna, M., Fynn, L., Mugore, M., Mabandla, S., Hosek, S., Celum, C., Bekker, L.-G., Daniels, J., & Medina-Marino, A. (2023). High study participation but diverging adherence levels: qualitatively unpacking PrEP use among adolescent girls and young women over two years in Eastern Cape, South Africa. Journal of Behavioral Medicine, 47(2), 320–333. https://doi.org/10.1007/s10865-023-00462-2

Brittain, K., Brown, K., Phillips, T., Zerbe, A., Pellowski, J., Remien, R. H., Mellins, C. A., Abrams, E. J., & Myer, L. (2023). Why do Integrated Maternal HIV and Infant Healthcare Services work? A Secondary Analysis of a Randomised Controlled Trial in South Africa. AIDS and Behavior, 27(12), 3831–3843. https://doi.org/10.1007/s10461-023-04097-x

Mantell, J. E., Zech, J. M., Masvawure, T. B., Assefa, T., Molla, M., Block, L., Duguma, D., Yirsaw, Z., & Rabkin, M. (2023). Implementing six multi-month dispensing of antiretroviral therapy in Ethiopia: perspectives of clients and healthcare workers. BMC Health Services Research, 23(1). https://doi.org/10.1186/s12913-023-09549-7

Robbins, R. N., Kluisza, L., Nguyen, N., Dolezal, C., Leu, C. S., Wiznia, A., Abrams, E. J., Anderson, P. L., Castillo-Mancilla, J. R., & Mellins, C. A. (2023). Measuring ART Adherence Among Young Adults with Perinatally Acquired HIV: Comparison Between Self-report, Telephone-Based Pill Count, and Objective Pharmacologic Measures. AIDS and Behavior, 27(12), 3927–3931. https://doi.org/10.1007/s10461-023-04107-y

Shen, Y., Franks, J., Reidy, W., Olsen, H., Wang, C., Mushimbele, N., Mazala, R. T., Tchissambou, T., Malele, F., Kilundu, A., Bingham, T., Djomand, G., Mukinda, E., Ewetola, R., Abrams, E. J., & Teasdale, C. A. (2023). Pre-exposure prophylaxis uptake concerns in the Democratic Republic of the Congo: Key population and healthcare workers perspectives. PLOS ONE, 18(11), e0280977. https://doi.org/10.1371/journal.pone.0280977

Meyers, K., Quigee, D., Zucker, J., Carnevale, C., Klein, J., Kim, T. Y., & Sobieszczyk, M. E. (2023). The Index of Engagement in PrEP Care: Evaluation of Psychometric Properties and Predictive Potential. JAIDS Journal of Acquired Immune Deficiency Syndromes, 94(3), 214–219. https://doi.org/10.1097/qai.0000000000003246

McCrimmon, T., Frye, V., Darisheva, M., Starbird, L., Cordingley, O., Terlikbayeva, A., Primbetova, S., Gilbert, L., El-Bassel, N., & West, B. S. (2023). “Protected Means Armed”: Perspectives on Pre-Exposure Prophylaxis (PrEP) Among Women Who Engage in Sex Work and Use Drugs in Kazakhstan. AIDS Education and Prevention, 35(5), 347–361. https://doi.org/10.1521/aeap.2023.35.5.347

Ferraris, C. M., D’avanzo, P. A., Jennings, L., Robbins, R. N., Nguyen, N., Leu, C.-S., Dolezal, C., Mgbako, O., Hsiao, N., Joska, J., Castillo-mancilla, J. R., Myer, L., Anderson, P. L., Belaunzarán-zamudio, P. F., Mellins, C. A., Orrell, C., & Remien, R. H. (2023). Acceptability and Feasibility of Providing Adherence Feedback Based on Tenofovir Diphosphate in Dried Blood Spots: Results from a Pilot Study Among Patients and Providers in Cape Town, South Africa. AIDS and Behavior, 27(10), 3478–3486. https://doi.org/10.1007/s10461-023-04063-7

de Vos, L., Mudzingwa, E. K., Fynn, L., Atujuna, M., Mugore, M., Gandhi, M., Celum, C., Hosek, S., Bekker, L., Daniels, J., & Medina‐Marino, A. (2023). Factors that influence adolescent girls and young women’s re‐initiation or complete discontinuation from daily oral PrEP use: a qualitative study from Eastern Cape Province, South Africa. Journal of the International AIDS Society, 26(9). Portico. https://doi.org/10.1002/jia2.26175

Teitelman, A. M., Tieu, H.-V., Chittamuru, D., Shaw, P. A., Nandi, V., Davis, A., Lipsky, R. K., Darlington, C. K., Fiore, D., & Koblin, B. A. (2023). A Randomized Controlled Pilot Study of Just4Us, a Counseling and Navigation Intervention to Promote Oral HIV Prophylaxis Uptake Among PrEP-Eligible Cisgender Women. AIDS and Behavior, 27(9), 2944–2958. https://doi.org/10.1007/s10461-023-04017-z

Darlington, C. K., Lipsky, R. K., Teitelman, A. M., Koblin, B. A., Davis, A., Walcott, M., Compton, P. A., & Tieu, H.-V. (2023). HIV risk perception, pre-exposure prophylaxis (PrEP) awareness, and PrEP initiation intention among women who use drugs. Journal of Substance Use and Addiction Treatment, 152, 209119. https://doi.org/10.1016/j.josat.2023.209119

Kluisza, L., Attoh-Okine, N.-D., Nguyen, N., Robbins, R. N., Leu, C.-S., Liotta, L., Morrison, C., Dolezal, C., Remien, R. H., Wiznia, A., Abrams, E. J., & Mellins, C. A. (2023). Condomless Sex Among HIV-affected AYA in an Era of Undetectable = Untransmittable and Pre-exposure Prophylaxis. AIDS and Behavior, 27(9), 2979–2987. https://doi.org/10.1007/s10461-023-04020-4

Zia, Y., Nambala, L., Stalter, R. M., Muwonge, T. R., Ssebuliba, T., Nakyanzi, A., Nampewo, O., Boyer, J., Morrison, S., Nsubuga, R., Bagaya, M., Nyanzi, R., Matovu, F., Yin, M., Wyatt, C., Mujugira, A., & Heffron, R. (2023). Depression and PrEP uptake, interruption, and adherence among young women in Uganda. AIDS Care, 35(9), 1365–1374. https://doi.org/10.1080/09540121.2023.2177250

Vora, A. S., Marroquin, M., Rosenthal, S. L., Broker, P., Jetelina, K., Tiro, J. A., & Francis, J. K. (2023). Residents and Fellows’ Confidence in Prescribing Pre-exposure Prophylaxis (PrEP). Academic Pediatrics, 23(6), 1282–1287. https://doi.org/10.1016/j.acap.2023.02.017

Jennings, L., Ferraris, C. M., Castillo-Mancilla, J. R., Robbins, R. N., Nguyen, N., Leu, C.-S., Dolezal, C., Hsiao, N., Mgbako, O., Joska, J., Myer, L., Anderson, P. L., Remien, R. H., & Orrell, C. (2023). Comparing Predictive Ability of Two Objective Adherence Measures in a Community-Based Cohort on Antiretroviral Therapy in South Africa: Tenofovir Diphosphate Concentrations and Electronic Adherence Monitors. JAIDS Journal of Acquired Immune Deficiency Syndromes, 93(4), 327–332. https://doi.org/10.1097/qai.0000000000003198

Restar, A., Minalga, B. J., Quilantang, Ma. I., Adamson, T., Dusic, E., van der Merwe, L.-A., Millet, G., Rosadiño, D., Laguing, T., Lett, E., Everhart, A., Phillips, G., Janamnuaysook, R., Seekaew, P., Baker, K., Ashley, F., Wickersham, J., Wallace, S. E., Operario, D., & Gamarel, K. E. (2023). Mapping Community-Engaged Implementation Strategies with Transgender Scientists, Stakeholders, and Trans-Led Community Organizations. Current HIV/AIDS Reports, 20(3), 160–169. https://doi.org/10.1007/s11904-023-00656-y

Hoffman, S., Jamison, K., Pathela, P., Gonzalez-Argoti, T., Rivera, A., Leu, C.-S., Hubbard, S., Castro, M., Borges, C., Gandhi, A., Edelstein, Z., Myers, J., Mantell, J. E., & Bauman, L. J. (2023). Health Care Provider Decisions to Initiate Oral HIV Preexposure Prophylaxis in New York City Public Sexual Health Clinics. Sexually Transmitted Diseases, 50(6), 386–394. https://doi.org/10.1097/olq.0000000000001782

Ruel, T., Penazzato, M., Zech, J. M., Archary, M., Cressey, T. R., Goga, A., Harwell, J., Landovitz, R. J., Lain, M. G., Lallemant, M., Namusoke-Magongo, E., Mukui, I., Permar, S. R., Prendergast, A. J., Shapiro, R., & Abrams, E. J. (2023). Novel Approaches to Postnatal Prophylaxis to Eliminate Vertical Transmission of HIV. Global Health: Science and Practice, 11(2), e2200401. https://doi.org/10.9745/ghsp-d-22-00401

Tross, S., Spector, A. Y., Ertl, M. M., Berg, H., Turrigiano, E., & Hoffman, S. (2022). A Qualitative Study of Barriers and Facilitators of PrEP Uptake Among Women in Substance Use Treatment and Syringe Service Programs. AIDS and Behavior, 27(4), 1162–1172. https://doi.org/10.1007/s10461-022-03853-9

Massey, E. S. G., Bazzi, A. R., Sian, C. R., Gebel, C. M., Bernstein, J. A., & Assoumou, S. A. (2022). “I’ve been 95% safe”: perspectives on HIV pre-exposure prophylaxis at a drug detoxification center: a qualitative study. AIDS Care, 35(4), 461–465. https://doi.org/10.1080/09540121.2022.2031853

Mgbako, O., Mathu, R., Gonzalez Davila, M., Mehta, M., Cabrera, J., Carnevale, C., Zucker, J., Gordon, P., & Olender, S. (2022). Immediate ART and clinical outcomes in New York City among patients newly diagnosed with HIV. AIDS Care, 35(4), 545–554. https://doi.org/10.1080/09540121.2022.2104799

Dahlby, L., Boyd, J., Knight, R., Philbin, M., Small, W., Kerr, T., & McNeil, R. (2022). The perspectives of street-involved youth who use drugs regarding the acceptability and feasibility of HIV pre-exposure prophylaxis: a qualitative study. AIDS Care, 35(4), 480–487. https://doi.org/10.1080/09540121.2022.2085868

Yao, T.-J., Malee, K., Zhang, J., Smith, R., Redmond, S., Rice, M. L., Frederick, T., Torre, P., Mellins, C. A., Hoffman, H. J., & Williams, P. L. (2023). In Utero Antiretroviral Exposure and Risk of Neurodevelopmental Problems in HIV-Exposed Uninfected 5-Year-Old Children. AIDS Patient Care and STDs, 37(3), 119–130. https://doi.org/10.1089/apc.2022.0189

Hanass-Hancock, J., Bhengu, N., Exner, T., Magusthwa, S., Harrison, A., Dolezal, C., Miller, L., Bauman, L., & Hoffman, S. (2023). Masibambane—Ladies Chat: Developing an Online Gender-Enhanced PrEP Information-Motivation Workshop for Young South African Women. AIDS Education and Prevention, 35(1), 14–35. https://doi.org/10.1521/aeap.2023.35.1.14

Penazzato, M., Kasirye, I., Ruel, T., Mukui, I., Bekker, A., Archary, M., Musoke, P., Essajee, S., Siberry, G. K., Mahy, M., Simnoue, D., Simione, B., Zech, J. M., Mushavi, A., & Abrams, E. J. (2023). Antiretroviral postnatal prophylaxis to prevent HIV vertical transmission: present and future strategies. Journal of the International AIDS Society, 26(2). Portico. https://doi.org/10.1002/jia2.26032

Meyers, K., Nguyen, N., Zucker, J. E., Kutner, B. A., Carnevale, C., Castor, D., Sobieszczyk, M. E., Yin, M. T., Golub, S. A., & Remien, R. H. (2022). The Long-Acting Cabotegravir Tail as an Implementation Challenge: Planning for Safe Discontinuation. AIDS and Behavior, 27(1), 4–9. https://doi.org/10.1007/s10461-022-03816-0

Karim, Q. A., Archary, D., Barré-Sinoussi, F., Broliden, K., Cabrera, C., Chiodi, F., Fidler, S. J., Gengiah, T. N., Herrera, C., Kharsany, A. B. M., Liebenberg, L. J. P., Mahomed, S., Menu, E., Moog, C., Scarlatti, G., Seddiki, N., Sivro, A., & Cavarelli, M. (2022). Women for science and science for women: Gaps, challenges and opportunities towards optimizing pre-exposure prophylaxis for HIV-1 prevention. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.1055042

Naicker, N., Yende-Zuma, N., Kharsany, A. B. M., Shozi, H., Nkosi, D., Naidoo, A., Garrett, N., & Abdool Karim, S. S. (2022). Pregnancy rates and outcomes in a longitudinal HIV cohort in the context of evolving antiretroviral treatment provision in South Africa. BMC Pregnancy and Childbirth, 22(1). https://doi.org/10.1186/s12884-022-04829-2

Pagkas-Bather, J., Duncan, D. T., Chen, Y.-T., Cursio, J., Del Vecchio, N., Mayer, K. H., Knox, J., Hanson, H., Eavou, R., & Schneider, J. A. (2022). Sleep Disturbance is Associated with Missing PrEP Doses Among Young Black Sexual Minority Men in The N2 study. AIDS and Behavior, 26(12), 3827–3833. https://doi.org/10.1007/s10461-022-03711-8

Fernández-Luis, S., Lain, M. G., Serna-Pascual, M., Domínguez-Rodríguez, S., Kuhn, L., Liberty, A., Barnabas, S., Lopez-Varela, E., Otwombe, K., Danaviah, S., Nastouli, E., Palma, P., Cotugno, N., Spyer, M., Giannuzzi, V., Giaquinto, C., Violari, A., Cotton, M. F., Nhampossa, T., … Maiga, A. (2022). Optimizing the World Health Organization algorithm for HIV vertical transmission risk assessment by adding maternal self-reported antiretroviral therapy adherence. BMC Public Health, 22(1). https://doi.org/10.1186/s12889-022-13543-9

Jao, J., Sun, S., Bonner, L. B., Legbedze, J., Mmasa, K. N., Makhema, J., Mmalane, M., Kgole, S., Masasa, G., Moyo, S., Gerschenson, M., Mohammed, T., Abrams, E. J., Kurland, I. J., Geffner, M. E., & Powis, K. M. (2022). Lower Insulin Sensitivity in Newborns With In Utero HIV and Antiretroviral Exposure Who Are Uninfected in Botswana. The Journal of Infectious Diseases, 226(11), 2002–2009. https://doi.org/10.1093/infdis/jiac416

Murphy, E. C., Danvers, A., Zamudio, A. R., Avila, K., Proehl, M., Gonzalez-Argoti, T., Mantell, J. E., Bauman, L. J., & Dolan, S. M. (2022). “Being able to do whatever you wanna do as a woman is important:” a qualitative exploration of contraception as a frame of reference for HIV prevention with PrEP. Reproductive Health, 19(1). https://doi.org/10.1186/s12978-022-01393-y

Mantell, J., Franks, J., Zerbe, A., Lamb, M. R., Reed, D. M., Omollo, D., Lahuerta, M., Naitore, D., El-Sadr, W. M., & Agot, K. (2022). MPrEP+ study protocol: a prospective cohort study assessing the feasibility and acceptability of an HIV pre-exposure prophylaxis (PrEP) strategy for male clients of female sex workers in Kisumu, Kenya. BMJ Open, 12(11), e064037. https://doi.org/10.1136/bmjopen-2022-064037

Watson, R. J., Chang, C. J., Feinstein, B. A., Moody, R. L., Caba, A., & Eaton, L. A. (2022). PrEP Stigma and logistical barriers remain significant challenges in curtailing HIV transmission among Black and Hispanic/Latinx cisgender sexual minority men and transgender women in the US. AIDS Care, 34(11), 1465–1472. https://doi.org/10.1080/09540121.2022.2098908

Mudzingwa, E. K., de Vos, L., Atujuna, M., Fynn, L., Mugore, M., Hosek, S., Celum, C., Bekker, L.-G., Daniels, J., & Medina-Marino, A. (2022). Factors influencing adolescent girls and young women’s uptake of community-based PrEP services following home-based HIV testing in Eastern Cape, South Africa: a qualitative study. AIDS and Behavior, 26(11), 3726–3739. https://doi.org/10.1007/s10461-022-03702-9